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Islet-activating protein (IAP) suppressed Ca2+-induced histamine release and phospholipase AZ activation 
in Gpp(NH)p-loaded mast cells. Since the guanine nucleotide-binding protein involved in adenylate cyclase 
inhibition is known to lose its function upon being ADP-ribosylated by IAP, the nucleotide-binding 
protein is likely to mediate Ca2+ -linked biosignalling leading to histamine secretion. 
Islet-activating protein Guanine nucleotide-binding protein CaZ’ Histamine secretion 
Arachidonic acid 
1. INTRODUCTION 
It was recently reported that application of 
micromolar ATP4- renders mast cells permeable to 
foreign compounds and that the lesions thus 
generated in the membrane can be resealed within 
seconds of adding Mg2+ to recover functionally in- 
tact cells [l]. A non-hydrolyzable GTP analogue 
such as Gpp(NH)p was introduced into the cytosol 
of mast cells by this technique. Histamine was 
secreted from these cells in response to addition of 
extracellular Ca2+ , suggesting that guanine 
nucleotide-binding regulatory proteins (N) may 
play a role in Ca’+-dependent regulation of ex- 
ocytosis [ 11. 
Islet-activating protein (IAP), pertussis toxin, is 
a specific modifier of the N protein (NJ that com- 
municates between membrane receptors and the 
* To whom correspondence should be addressed 
Abbreviations: Gpp(NH)p, guanyl-5 ’ -yl P,y-imido- 
diphosphate; N, and Nr, the stimulatory and inhibitory 
guanine nucleotide-binding regulatory components of 
adenylate cyclase, respectively 
adenylate cyclase catalytic protein in an inhibitory 
fashion [2]. Ni loses its function as the com- 
municator when its a-subunit (kfr = 41000) is 
selectively ADP-ribosylated by IAP [3-91. We 
now report that less histamine and less arachidonic 
acid were released in response to Ca2+ addition 
from the Gpp(NH)p-loaded mast cells when the 
cells had been exposed to IAP. The results show 
that the IAP substrate with M, = 41 Ooo may play 
an important role in Ca2+-mobilizing receptor- 
mediated histamine secretion from mast cells. 
2. MATERIALS AND METHODS 
IAP was purified from the 2-day culture super- 
natant of Bordetella pertussis as in [lO,ll]. Rat 
peritoneal mast cells (lo6 cells/ml), isolated and 
purified as in [12], were first exposed to IAP 
(10 ng/ml or as indicated in fig.3) or its vehicle for 
2 h at 37°C in Eagle’s minimum essential medium 
containing 0.2% bovine serum albumin under an 
atmosphere of 95% 02/5% CO2. The medium for 
this IAP treatment was supplemented with 0.2 
&i/ml of [l-14C]arachidonic acid (52.9 mCi/ 
mmol, New England Nuclear). During this 2 h 
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preincubation time, [14C]arachidonic acid was in- 
corporated into cellular phospholipids; about 64% 
was found in phosphatidylcholine (submitted). 
The cells were then washed 3 times with a 
divalent cation-free solution (137 mM NaCl, 
2.7 mM KCI, 20 mM Hepes, 5.6 mM glucose, 
1 mg/ml bovine serum albumin, 30pM EDTA; 
pH 7.7) and suspended in the same solution (1.5 x 
lo5 cells/40 ~1). The cell suspension was incubated 
first for 5 min as such, then for 5 min after the ad- 
dition (10 ~1) of ATP and Gpp(NH)p to final con- 
centrations of 20/1M (or as indicated in text) and 
1 mM (or as indicated in fig.2), respectively, and 
finally for 5 min after the addition of MgClz 
(2.5 pl) to 2 mM. These incubations were per- 
formed at 37°C in air under oscillation. These 
cells, washed once and resuspended in the divalent 
cation-free solution, were further incubated for 
10 min (or as indicated in fig.1) at 37°C with the 
addition of Ca’+ to make the final concentration 
2.5 mM and pH 7.5. The reactions were quenched 
with Tris-buffered saline and the supernatant ob- 
tained by centrifugation was analyzed for 
histamine and 14C-labeled arachidonic acid and its 
metabolites as in [12] (submitted). 
3. RESULTS 
Here, rat peritoneal mast cells were first exposed 
to IAP for 2 h. This prolonged IAP treatment was 
essential, because there is a lag time inevitably 
preceding the onset of IAP action on intact cells 
(including mast cells [12]) reflecting the time re- 
quired for the active component of the toxin to 
traverse the plasma membrane to reach the IAP 
substrate inside [ 13- 151. These 2-h preincubated 
cells were less susceptible to ATP4- than were the 
fresh cells. The addition of 5 PM ATP4- [with 
1 mM Gpp(NH)p] to cell suspensions, followed by 
Mg2+ for the purpose of resealing, resulted in the 
subsequent secretion of as much histamine as 30% 
or more of the total cellular content, in response to 
the addition of 2.5 mM Ca’+, from fresh cells. 
This confirms the original finding in [l], but only 
12.1% histamine was released from 2-h prein- 
cubated cells under the same conditions. As the 
concentration of ATP4- was increased to 10, 20 
and 30pM in the presence of 1 mM Gpp(NH)p, 
20.1, 42.6 and 61.2% of cellular histamine was 
released, respectively, from the 2-h preincubated 
cells in response to the subsequent addition of 
Ca2+; the corresponding values were 3.0, 6.5 and 
15.0% when Gpp(NH)p was omitted from the 
ATP4--containing medium. The following ex- 
periments were hence conducted with 2-h prein- 
cubated mast cells that were then treated with 
ATP- at 20pM, a concentration evoking a 
significant effect of Gpp(NH)p on Ca2+-dependent 
histamine release. The incorporation of 
[ 14C]arachidonic acid into phospholipids during 
this 2 h preincubation period was not affected by 
the presence of IAP. 
Fig.la illustrates time courses of histamine 
release from Gpp(NH)p-loaded mast cells in 
response to the addition of 2.5 mM Ca2+. 
Histamine was released following a definite lag 
period of 15-30 s (see inset). The secretion con- 
tinued at a high rate for 1.5 min and declined 
rapidly thereafter. This Ca2+-induced histamine 
secretion was associated with release of 14C-labeled 
compounds which occurred immediately after 
Ca2+ addition without delay (fig.lb). Thin-layer 
chromatography on a silica gel plate revealed that 
roughly 90% of the labeled products was 
(96) 
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Fig. 1. Time courses for Gpp(NH)p-dependent histamine 
(a) and arachidonic acid (b) release from permeabilized- 
resealed mast cells in response to Ca’+. Mast cells 
treated with IAP (0) or its vehicle (0) were loaded with 
Gpp(NH)p and [l-14C]arachidonic a id as described in 
section 2. Cells were then incubated for the times 
indicated after the addition of Ca’+. Histamine release 
is expressed as Qo of the total cellular content before 
incubation. (Inset) Release during the initial short time. 
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arachidonic acid itself (submitted). Prior treatment 
of cells with IAP was very effective in inhibiting 
secretion; the rate of release of histamine or 
arachidonate from IAP-treated cells was lower 
than the release from non-treated cells at any time 
of incubation with Ca2+ (fig.la,b). 
Introduction of Gpp(NH)p into the cytosol of 
mast cells was a prerequisite for the release of 
histamine and arachidonate upon subsequent addi- 
tion of extracellular Ca2+; their release was depen- 
dent on the concentration of the GTP analogue 
added to the ATP4--containing medium (fig.2). 
There seemed to be an optimum Gpp(NH)p con- 
centration (l-3 mM) for histamine secretion in ac- 
cordance with [l]. This was also the case with 
arachidonate release. Less histamine and less 
arachidonate were released from IAP-treated cells 
than from non-treated cells at any concentration of 
Gpp(NH)p, particularly below its optimum 
concentration. 
IAP inhibited Caz+-induced histamine and 
arachidonate release from Gpp(NH)p-loaded cells 
in a concentration-dependent manner (fig.3). The 
maximal inhibition induced by the highest concen- 
tration of IAP was around 50% of the control 
([IAP] = 0) value for either histamine or 
arachidonate release. This inhibition was definitely 
100 
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Fig.2. Effect of Gpp(NH)p on Ca’+-induced histamine 
(a) and arachidonic acid (b) release from permeabilized- 
resealed mast cells. Experiments were carried out with 
IAP-treated (0) or non-treated (0) cells as in fig.1 
except for changes in the Gpp(NH)p concentration as 
shown on the abscissa. 
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Fig.3. Concentration-dependent inhibition by IAP of 
Ca’+-induced, Gpp(NH)p-dependent release of hist- 
amine and arachidonic acid from permeabilized-resealed 
mast cells. Experiments were carried out as in fig.1 
except for changes in the concentration of IAP as shown 
on the abscissa. 
smaller than the 75-90% inhibition observed for 
compound 48/80-induced histamine and arachi- 
donate release from intact mast cells ([ 121, submit- 
ted), although the concentration (-0.3 ng/ml) of 
the toxin required for half-maximal inhibition was 
of the same order of magnitude for either case. 
IAP interacts with the ~-subunit of Ni, while 
cholera toxin catalyzes ADP-ribosylation of the LY- 
subunit of N, that is involved in receptor-mediated 
adenylate cyclase activation [2]. In some ex- 
periments, IAP was replaced by cholera toxin 
(1 pg/ml)i to compare the effects of both toxins. 
The cellular content of cyclic AMP was 641, 648 
and 2660 fmol/106 cells (means of duplicate obser- 
vations) immediately after Gpp(NH)p loading and 
Mg2+-induced resealing for control, IAP-treated 
and cholera toxin-treated cells, respectively. The 
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Effects of inhibitors of phospholipid and arachidonate metabolism on 
Ca’+-induced and Gpp(NH)p-dependent release of histamine and arachidonic acid 
from permeabilized-resealed cells 
Inhibitor Histamine Arachidonate 
release release 
Woo) (cpm/105 cells) 
- Ca’+ + Ca2+ - Ca2+ + Ca2+ 
None 4.8 23.2 203 588 
p-Bromophenacyl bromide 
(10 PM) 4.9 5.1 227 375 
Indomethacin (10 PM) 5.0 23.3 193 593 
Nordihydroguaiaretic acid 
(100 rM) 10.6 11.0 280 791 
Inhibitors were added to the media used for 5 min incubation immediately after 
MgClz addition and used for the final 10 min incubation with (or without) 2.5 mM 
Ca2+. Mast cells not treated with IAP were used. Data are means of duplicate 
determinations 
marked increase in cyclic AMP may reflect cholera 
toxin-catalyzed ADP-ribosylation of N,. These 
cells were further incubated with 2.5 mM Ca’+. 
Histamine release in response to Ca’+ was 35.0, 
18.2 and 37.6070, while arachidonate release was 
572, 315 .and 610 cpm/105 cells, from control, 
IAP-treated and cholera toxin-treated cells, respec- 
tively (means of duplicate observations). Thus, the 
action of IAP in preventing Ca*+-induced 
histamine and arachidonate release from 
Gpp(NH)p-loaded mast cells was not mimicked by 
cholera toxin. The IAP-sensitive a-subunit of Ni, 
rather than the cholera toxin-sensitive subunit of 
N,, appears to play a role in Ca*+-induced 
histamine release; this role is unlikely to be 
mediated by cyclic AMP because histamine release 
was not influenced by cholera toxin-induced ac- 
cumulation of cyclic AMP. 
The effects of inhibitors of arachidonate 
metabolism were studied, the results being listed in 
table 1. Ca*+-induced arachidonate release was 
markedly inhibited by p-bromophenacyl bromide, 
indicating that arachidonate released was a pro- 
duct of phospholipase AZ-catalyzed breakdown of 
phospholipids. This phospholipase-catalyzed reac- 
tion appears to be responsible for histamine secre- 
tion, since Ca*+ was no longer stimulatory to the 
secretion in the presence of p-bromophenacyl 
bromide. Indomethacin was without effect; fur- 
ther metabolism of arachidonate to prostaglandins 
would not be directly related to histamine secre- 
tion. Nordihydroguaiaretic acid increased the 
basal histamine secretion occurring in the absence 
of extracellular Ca*+, but abolished the action of 
Ca*+ to stimulate the amine secretion despite 
arachidonate release being normally stimulated by 
this divalent cation (table 1). Product(s) of a lipox- 
ygenase reaction might play a certain role in ex- 
ocytosis of histamine granules [ 16,131. 
4. DISCUSSION 
Our results confirm the proposal [I] that a class 
of guanine nucleotide-binding proteins may play a 
role in the entry of Ca*+ into mast cells causing 
histamine release. Arachidonic acid was also 
released from the Gpp(NH)p-loaded mast cells in 
response to Ca*+ probably reflecting phospholip- 
ase AZ activation. The nucleotide-binding protein 
involved appears to be one of the IAP substrates, 
since Gpp(NH)p-dependent, Ca*+-induced hist- 
amine and arachidonic acid release was markedly 
suppressed by prior treatment of mast cells with 
the toxin. The pertussis toxin is now known to 
abolish the functions of nucleotide-binding pro- 
teins (Ni [2,5-71 and transducin [18]) as a result of 
ADP-ribosylation of their a-subunits [3,4,8,9,19]. 
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A protein with the same molecular mass as the LY- 
subunit of Ni was also ADP-ribosylated by IAP in 
mast cells (submitted). 
Exposure of guinea pig neutrophils [20] or 
mouse 3T3 fibroblasts (submitted) to IAP resulted 
in marked inhibition of arachidonic acid release 
from these cells that occurred upon stimulation of 
membrane receptors by a chemotactic peptide, 
thrombin or platelet-activating factor. The IAP- 
induced inhibition was paralleled by ADP- 
ribosylation of a membrane 41-kDa protein [20]. 
Arachidonic acid release is a Ca’+-dependent 
cellular process responsible for histamine secretion 
from mast cells or basophils [16,17]. Thus, this 
report suggests that an IAP-susceptible guanine 
nucleotide-binding protein mediates biosignalling 
via Ca2+-mobilizing receptors in mast cells. 
Whether the nucleotide-binding protein is the cy- 
subunit of Ni is a problem for further 
investigation. 
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